Colca Ms, a leading partner in the supply chain
Both on import, packaging, labeling and distribution
COLCA MS supports AlgoTx in the ACT study, a phase 2 multicenter, randomized clinical trial. The ACT study obtained an FDA IND and clearance from many countries in the European Union
AlgoTx is a French BIOTECH company that develops innovative solutions to relieve patients of complex and difficult to treat pain.
ATX01 inhibits pain messaging caused by peripheral neuropathy and was granted “Fast-Track” designation by FDA for its development in chemotherapy-induced peripheral neuropathy, a frequent side-effect of such cancer treatments.
COLCA MS is a leading partner in the supply of ATX01. COLCA MS manages importation of Drug Product imports to France, performs randomized packaging and labeling services, and ensures the distribution of IMPs* to clinical investigator centers in the European Union and the United States.
Learn more of AlgoTx:
*FDA : Food and Drug Administration
*IMPs : Investigational Medicinal Products
